Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Wyn - yes. It is huge. Baffles me as to what makes it a non-event!!?
Anyway, time will tell. The SP will do its thing. I see the massive value in next week.
Hold on a minute. Let’s just have a look at this ‘data won’t be a catalyst’ theme that’s playing out.
The data will underpin the degree of response a terminal patient has seen whilst on the drug. As in, a SIGNIFICANT response in quantifiable terms. Not just ‘remarkable’ from AS. A percentage reduction, aligned to RECIST.
To contextualise this, when we get this data, it’ll read across to other trials. And confirm we have succeeded where others have failed. VERY simple. And VERY valuable.
Now, tell me data won’t be a driver?
He’s either lying, ramping, or telling truth that adds meat to the unicorns bones.
Rhubarb.
The situation hasn’t changed since the 19th September. We’ve had no more news to analyse, yet these ‘genuine questions’ appear now, days before an update that doesn’t appear to be SP reflective.
Load of rubbish.
The RNS giving a weeks notice for data to UNDERPIN what we already know is stellar has brought out a bizarre amount of concerned holders.
Sticky is back. Twitter is awash with ‘sell all and derisk your investment’. New poster on the thread below leading with ‘please help me’.
All bizarre. Wednesday is an exciting day for those wanting to see under the hood. Me being one of them.
Ignore the new, odd new posters. And our friends of old! Especially the reptile.
Whilst my view is the ppposite to yours Cj, we agree on clarity. It’s always been ASs issue and one that can’t be shook. Wooly.
Give us the full data set - it’s been 2.5 years!!!!! Madness. And a full view on the route to commercialisation. Likely hood of where the first deal comes from. It’s torturous. And there’s no real excuse. He hid behind the ‘would t be right to discuss patient detail until trial is finished’. Lo and behold, he now is because of the pressure he’s under.
He’s just a bully Mark, as you know. Got carried away - again, apologies.
Sorry Mark - my mistake. Apologies.
Charming Mark. You’re an integral part of the TG who sells a load of these rumours. I’m sorry you feel aggrieved to be called out on such rumours never being true.
And Ophidian. What a pathetic comment… bet you were a laugh in the playground.
Keep the rumours coming. Keep the sources hidden. Keep getting every single call wrong. Keep up the ‘science’.
Ps - you are aware that the crew you used to fraternise with think you’re a charlatan? Apart from Mr Mitchell of course.
Mark
Very good friend… bless. This is a BB. Get over yourself.
Any more rumours??
Like I said last week - your own congregation have disowned you. You have one supporter left.
Strange how I’m old, too. The personal attacks and name calling continues. A lovely fella.
One of goes without saying Bella. Kinda what I implied. Jeeez…
We’ll never know who the seller is. There’s always a seller. There should be no fascination.
It’s either a massive lie or a progressive route to safe drugs to saves people lives. And people invested make a few quid.
The rest is just noise. And that noise now includes some old names, plus borg out with his crayons.
It will stay the same. The notes are paid for. AS stated they’re involved in their production.
All the same Apre, correct. Big give away is their love for Myles.
It’s a loan. Not an investment.
Vert - what are you implying?
Good points indeed.
Gmcc - as much as you like to wind me up, I shouldn’t get wound up. We want the same thing. Good luck.
Gmcc - what a bizarre past time to have. Each to their own I suppose.
Carry on knocking my investment? Another bizarre statement.
Thanks for the view on my personal situation. It’s in great hands actually. 40+ years for it to come good, so not all bad, as you say. Again, another passive aggressive statement.
Agree BV. That’s how I read it. They want a ‘cure’ story.
Gmcc - thanks for yet another passive aggressive and pointless/old post.
Dr. Smith needs all the support he can get. You’ll know that there are a lot of shareholders upset with his lack of commercial progress and support of the SP. This info is circulated by the group you’re in. Telegram for clarity.
The company is looking for a CBO. They’ve appointment a new CMO. They’ve appointed a new comms agency. They’ve appointed Shaun Chilton. These appointments are all to help AS provide strategic commercial direction because he can’t manage it.
The SP is barely above first dosing. No inflection point. Wasted a load of cash on Dx. Thankfully the tech has hold of is of immense significance.
If your investment is based solely on AS and the Affimer - you need all the luck in the world.